LAS VEGAS - CVS Health released a white paper at the HLTH conference on Nov. 15—widely reported on Nov. 16—finding that GLP-1 medications cut hospitalizations by up to 42% but still leave employers paying $3,900 more per patient over three years unless net prices drop to $350 a month.
Medical Savings Trail Prescription Costs Under Current Employer Pricing
Analyzing Aetna insurance claims from 2023 to 2025, CVS found GLP-1 users experienced 34% to 42% lower hospitalization rates and 10% to 12% fewer emergency room visits in years one and two. But they spend $13,300 more on prescriptions, netting out to $3,900 in additional costs per person taking GLP-1s, CVS found," Healthcare Dive reported.
Medicare Pilot Pricing Sparks Call for Drugmaker Discounts
Employers currently pay net prices averaging $617 to $766 monthly, compared with $245 a month charged to Medicare by Eli Lilly and Novo Nordisk in a federal pilot. They're still making money at that. So why are they charging such high prices to employers?" CVS Chief Medical Officer Amy Compton-Phillips told Healthcare Dive.



